Neoadjuvant chemotherapy with FOLFOX: Improved outcomes in Chinese patients with locally advanced gastric cancer
Authors:
- Cherry E. KohCKCherry E. Koh
- 20 December 2011
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 105 (8) , 793-799
Abstract
Background: Although the role of peri‐operative chemotherapy is established in the treatment of locally advanced gastric cancer, the optimal regime remains to be determined. FOLFOX has been used in palliative setting with good response rates but its role in a neoadjuvant setting is not well established.Methods: This is a prospective non‐randomized study comparing peri‐operative FOLFOX versus adjuvant FOLFOX in patients with resectable locally advanced gastric cancer. Response to chemotherapy was assessed according to WHO criteria and pathological changes. Kaplan–Meier log rank test was used to calculate and compare survival differences.Results: There were 73 patients (neoadjuvant = 36). Complete and partial response was observed in 2 (6%) and 21 (64%) patients, respectively. Four‐year overall survival (OS) in the neoadjuvant arm was 78% versus 51% in the adjuvant arm (P = 0.031). Subgroup analysis found R0 resection (86% vs. 55%, P = 0.011) and patients with proximal cancers (87% vs. 14%, P < 0.001) to have improved OS. The most common side effect was grade 1–2 leukopenia. There were no grade 3 neuropathies, grade 4 cytopaenias, or treatment related deaths.Conclusion: Peri‐operative treatment with FOLFOX shows promise in patients with resectable locally advanced gastric cancer. It warrants further evaluation and should be considered an alternative to peri‐operative ECF. J. Surg. Oncol. 2012; 105:793–799.Keywords
This publication has 42 references indexed in Scilit:
- A Pilot Study of Oxaliplatin, Fluorouracil and Folinic Acid (FOLFOX-6) as First-Line Chemotherapy in Advanced or Recurrent Gastric CancerChemotherapy, 2008
- Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral FluoropyrimidineNew England Journal of Medicine, 2007
- East Meets West in the Treatment of Gastric CancerNew England Journal of Medicine, 2007
- Palliative chemotherapy for advanced gastric cancerAnnals of Oncology, 2004
- Chemotherapy for operable gastric cancer: results of the Dutch randomised FAMTX trialEuropean Journal of Cancer, 1999
- First demonstration of anti-lymphoma activity of BCL-2 antisense molecule-G3139; Results of phase I/IIA clinical trialEuropean Journal of Cancer, 1997
- Systemic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapyCancer, 1997
- Preoperative chemotherapy for stage III–IV gastric carcinoma: Feasibility, response and outcome after complete resectionBritish Journal of Surgery, 1995
- Preoperative and Postoperative Combination Chemotherapy for Potentially Resectable Gastric CarcinomaJNCI: Journal of the National Cancer Institute, 1993
- Chemotherapy and surgery for locally advanced cancer of the cardia and fundus: Phase II study with methotrexate and 5-fluorouracilBritish Journal of Surgery, 1991